HomeLBank Stocks
PAVmed Inc
PAVmed Inc

PAVmed Inc (PAVM)

24HHigh$3.6924HLow$2.61
$2.70
-0.25%

Last updated: 2026-10-07 10:19:20

K-Line Chart, actual market data is subject to the trading page.

Key Data

Prev. Open
$3.61
Prev. Close
$2.70
Prev. Day's Range
$2.61 - $3.69
52W Range
$2.61 - $17.99
Trading Volume
174.02K
MC
$21.269M
P/E Ratio
--
EPS
$-14.20

Company Overview

NASDAQ

PAVmed Inc. is a medical device company in the United States. The company is headquartered in New York, New York.

SectorHEALTHCARE
IndustryMEDICAL DEVICES
Headquarters360 MADISON AVENUE, NEW YORK, NY, UNITED STATES, 10017
CountryUSA
Listing Date2016-07-27
Fiscal Year Ended2026-06-30
Shares Outstanding7.996M
CIK Code1624326

Financial Metrics

Indicator2026-06-302026-03-312025-12-312025-09-30
Income$33K$22K$52K$5K
Operating Expenses$122K$117K$103K$55K
Net Income-$5.384M-$60K-$1.263M-$5.383M
Net Profit Margin-16315.2%-272.7%-2428.8%-107660.0%
Earnings Per Share--$-0.04$-1.63$-7.49
EBITDA-$6.596M-$1.041M-$2.734M-$5.981M
Effective Tax Rate---556766.9%---5273.7%

FAQ

PAVmed Inc. is a diversified medical technology company specializing in innovative healthcare solutions. Its portfolio focuses on diagnostics, medical devices, and digital health technologies aimed at improving patient outcomes and addressing unmet needs in the sector.
PAVmed Inc. operates within the healthcare sector and specifically in the medical devices and diagnostics industry. This sector focuses on developing technologies to diagnose, monitor, and treat health conditions efficiently.
PAVmed Inc.'s revenue growth is primarily driven by the commercialization of its diagnostic platforms, such as EsoGuard and the broader portfolio of medical technologies. Expanding market adoption and integration into healthcare systems contribute significantly to its financial performance.
PAVmed Inc. faces competition from other medical technology companies focused on diagnostics and medical devices, including industry leaders such as Medtronic, Boston Scientific, and more specialized firms offering similar products or solutions.
No, PAVmed Inc. does not currently pay dividends to shareholders. The company appears to focus on reinvesting in research and development to grow its product portfolio and advance its long-term strategic initiatives.
Investing in PAVmed Inc. involves risks such as regulatory challenges, the competitive landscape in the healthcare technology sector, potential delays in product commercialization, and overall market volatility. Investors should carefully consider these risks alongside the company’s growth initiatives.
PAVmed Inc. has opportunities tied to the expanding demand for advanced diagnostic tools and innovative medical devices. Its focus on addressing unmet needs and its diverse portfolio provide potential for revenue growth and increased market share.
Investors can monitor PAVmed Inc.'s financial performance by reviewing its quarterly earnings reports, SEC filings, and key metrics such as revenue growth, product commercialization updates, and cash flow figures. Staying informed about industry trends is also essential.
Risk Warning
  1. 1.Stock prices may fluctuate significantly; invest with caution. Past performance is not indicative of future results.
  2. 2.Digital asset trading involves multiple risks, including market and technical risks. Please make rational decisions and allocate assets wisely.
  3. 3.The information contained on this page is for reference only and does not constitute any investment advice.